Neurabin-1 (also known as PPP1R18 for Protein Phosphatase 1 Regulatory Subunit 18) is a neuron-specific postsynaptic scaffolding protein that plays critical roles in organizing the actin cytoskeleton, anchoring synaptic proteins, and regulating synaptic formation, maintenance, and plasticity. As a highly enriched protein in dendritic spines, neurabin-1 serves as a molecular hub that connects the actin-based skeleton of spines with key signaling molecules including protein phosphatase 1 (PP1), making it essential for proper synaptic function and cognitive processes[1].
The protein's unique structure enables it to bind F-actin directly, recruit PP1 to postsynaptic sites, and organize additional scaffolding proteins at excitatory synapses. This multifaceted approach to postsynaptic organization makes neurabin-1 a critical regulator of spine morphology and synaptic plasticity, with implications for neurodegenerative diseases where synaptic loss is a hallmark feature.
Neurabin-1 is an 784-amino acid protein with a molecular weight of approximately 88 kDa. Its distinct domain organization reflects its dual roles in actin organization and protein phosphatase recruitment:
F-Actin Binding Domain (residues 1-120): Located at the N-terminus, this domain mediates direct binding to filamentous actin (F-actin). It contains:
PP1-Binding Domain (residues 150-300): Contains the canonical RVxF motif required for PP1 binding:
PDZ-Domain Binding Motif (residues 770-784): C-terminal PDZ ligand:
Coiled-Coil Regions (residues 320-450): Protein-protein interactions
The F-actin binding domain of neurabin-1 adopts a β-sheet structure similar to cofilin, enabling:
The PP1-binding domain adopts a fold that positions the RVxF motif for high-affinity interaction with the PP1 catalytic subunit, forming an inhibitory complex that regulates PP1 activity at postsynaptic sites[2].
Dendritic spines are small actin-rich protrusions that receive most excitatory synaptic inputs in the brain. Neurabin-1 is essential for their formation and maintenance:
Spine Morphogenesis:
During development, neurabin-1 expression increases as spines form:
Spine Architecture:
Neurabin-1 contributes to the distinctive architecture of dendritic spines:
Neurabin-1 serves as a postsynaptic scaffold protein that organizes the synaptic proteome:
Protein-Protein Interactions:
Signaling Hub Functions:
Neurabin-1 integrates multiple signaling pathways:
Synaptic plasticity—the activity-dependent modification of synaptic strength—is fundamental to learning and memory:
Long-Term Potentiation (LTP):
Neurabin-1 participates in LTP[3]:
Long-Term Depression (LTD):
Neurabin-1 function is also required for LTD[4]:
Actin Dynamics Regulation:
The actin cytoskeleton is the primary driver of structural plasticity[5]:
Neurabin-1 plays critical roles in postsynaptic signal transduction:
Protein Phosphatase 1 Targeting:
PP1 is a major postsynaptic phosphatase[6] with substrates including:
By targeting PP1 to specific postsynaptic sites, neurabin-1 controls the phosphorylation state and function of these proteins, modulating synaptic strength.
Integration with Kinase Cascades:
阿尔茨海默病(AD)的最早病理特征之一是突触功能障碍和丧失,与认知功能下降密切相关[8]。Neurabin-1在该过程中发挥作用:
突触形态改变:
淀粉样蛋白-β毒性:
淀粉样蛋白-β(Aβ)寡聚体是AD的核心毒性物质,与突触功能障碍直接相关[9]:
Tau病理与突触:
Tau病理是AD的另一个核心特征[10]:
neurabin-1在AD中功能异常涉及多个分子机制:
淀粉样蛋白-V-actin相互作用:
蛋白磷酸酶1功能改变:
neurabin-1代表AD的一个潜在治疗靶点:
稳定突触结构:
恢复突触可塑性:
帕金森病(PD)的特征是黑质致密部多巴胺能神经元选择性丢失,但突触功能障碍也发生在其他脑区[11]:
突触前功能:
突触后功能:
虽然对neurabin-1在PD中的直接研究有限,但基于其功能,可以推断潜在的作用:
与α-突触核蛋白病理学的相互作用:
Neurabin-1与精神疾病相关[12]:
肌动蛋白稳定剂:
蛋白质磷酸酶调节剂:
Neurabin-1是一种神经元特异性的突触后支架蛋白,在树突棘组织、突触可塑性和信号转导中发挥关键作用。其F-actin结合和蛋白磷酸酶1靶向的双重功能使其成为突触功能的重要调节器。在阿尔茨海默病和帕金森病等神经退行性疾病中,突触功能障碍是核心病理特征,而neurabin-1正是参与这一过程的关键蛋白。理解neurabin-1在突触功能和疾病中的详细作用可能为这些破坏性疾病提供新的治疗策略。
Satoh A, et al. Neurabin, a neural tissue-specific F-actin binding protein. Nature Cell Biology. 1999. ↩︎
Huang J, et al. Protein phosphatase 1 anchoring by neurabin. Journal of Biological Chemistry. 2004. ↩︎
Malinow R. Molecular mechanisms of long-term potentiation. Science. 2003. ↩︎
Collingridge GL, et al. Mechanisms of long-term depression in the hippocampus. Physiological Reviews. 2010. ↩︎
Actin cytoskeleton regulation in synaptic plasticity. Nature Reviews Neuroscience. 2008. ↩︎
Brautigan DL, Shenolikar S. Protein phosphatase 1 in neuronal function. Annual Review of Biochemistry. 2020. ↩︎
p35/cdk5 kinase regulates actin dynamics in dendritic spines. Journal of Neuroscience. 2004. ↩︎
Hernandez MX, et al. Molecular mechanisms of synaptic loss in Alzheimer's disease. Brain Pathology. 2022. ↩︎
Manczak M, Reddy PH. Amyloid-beta oligomers and synaptic dysfunction. Journal of Alzheimer's Disease Reports. 2023. ↩︎
Ballatore C, et al. Tau pathology and synaptic dysfunction. Brain. 2007. ↩︎
Cheng W, et al. α-Synuclein and synaptic dysfunction in PD. Neurobiology of Disease. 2011. ↩︎
Ip CS, et al. Neurabin-1 in psychiatric disorders. Molecular Psychiatry. 2011. ↩︎